Sois Formulations Private Limited

Sois Formulations Private Limited - trading in Ambala Cantt, Haryana, India. FY 2026 financials & compliance.
CIN U24100HR2009PTC039273 Incorporated 07 July 2009 ROC Haryana HQ Ambala Cantt, Haryana, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2025
₹2.67 Cr
▼ 23% YoY
Net profit · FY 2025
₹3.46 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹7.53 Lakh
EBITDA margin 2.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Sois Formulations Private Limited

Data last updated:

Sois Formulations Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 07 July 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24100HR2009PTC039273. Its GSTIN is 06AAOCS0304E1ZR (Haryana).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Sudhir Gupta and Kapil Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6268/28 Nicholson Road, Ambala Cantt, Haryana, India – 133001.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.67 Cr, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹3.46 Lakh (net margin 1.3%) and EBITDA of ₹7.53 Lakh (EBITDA margin 2.8%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 4% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24100HR2009PTC039273
Registration Number 039273
Incorporation Date 07 July 2009
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Sois Formulations Private Limited's registered office is in Ambala Cantt, Haryana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    6268/28 Nicholson Road, Ambala Cantt, Haryana, India – 133001
  • Industry
    Trading, Other Wholesale, Wholesale

To see the full contact details of Sois Formulations Private Limited, buy the company report.

Comprehensive company report
Sois Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sois Formulations is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Sois Formulations Private Limited, buy the company report.

Financials of Sois Formulations Private Limited

FY 2025 filings available

Sois Formulations Private Limited reported revenue of ₹2.67 Cr (down 23% YoY) for FY 2025.

Revenue · FY 2025
₹2.67 Cr ▼ 23%
Net profit · FY 2025
₹3.46 Lakh margin 1.3%
EBITDA · FY 2025
₹7.53 Lakh margin 2.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 11%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 52%
3 years · compounded
▼ 32%
5 years · compounded
▼ 23%

Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 23% fall in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.53 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.46 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.8%
Net Profit Margin1.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sois Formulations Private Limited, buy the company report.

Board of directors of Sois Formulations Private Limited

Sois Formulations has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sudhir GuptaDirector07 Jul 200917 Years 3 MonthsCurrent
Kapil GuptaDirector07 Jul 200917 Years 3 MonthsCurrent
Aditya GuptaDirector01 Mar 201016 Years 7 MonthsCurrent

Peer comparison

Sois Formulations Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Medicure Formulations Private Limited₹2.69 Cr (FY 2025)22.0%Thane, Maharashtra, India
Zaria Pharmaceuticals Private Limited₹2.69 Cr (FY 2025)-20.0%Thane, Maharashtra, India
Med-Esales Life Sciences Private Limited₹2.68 Cr (FY 2025)-1.0%Agra, Uttar Pradesh, India
Cnscure India Private Limited₹2.67 Cr (FY 2024)184.0%Delhi, India
Sois Formulations Private Limitedthis company₹2.67 Cr (FY 2025)₹3.46 Lakh1.3%-23.0%Ambala Cantt, Haryana, India
Regbex Life Sciences Private Limited₹2.66 Cr (FY 2025)10.0%Salem, Tamil Nadu, India

To see the full peer comparison of Sois Formulations Private Limited, buy the company report.

Auditor

Sois Formulations Private Limited is audited by AJAY MITTAL AND COMPANY for the financial year 2017.

Auditor firmFinancial yearFirm registration number
AJAY MITTAL AND COMPANYFY 201704770N

Shareholding

The shareholding of Sois Formulations Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sois Formulations Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sois Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Sois Formulations has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAOCS0304E1ZRHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Sois Formulations Private Limited, buy the company report.

Recent activity

Sois Formulations Private Limited has 3 board changes on record since 2009: 3 appointments. The latest: Aditya Gupta was appointed as Director on 01 Mar 2010.

AGM
Sois Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sois Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Appointed
Aditya Gupta was appointed as Director.
Appointed
Kapil Gupta was appointed as Director.
Appointed
Sudhir Gupta was appointed as Director.
Incorporation
07 Jul 2009
Sois Formulations Private Limited was registered on 07 Jul 2009 with Roc Haryana & aged 17 years 3 months as per MCA records.

Frequently asked questions

Sois Formulations is an active private limited company based in Ambala Cantt, Haryana, India. The company works in other wholesale, within the trading industry. It was incorporated on 07 July 2009 (17+ years old) and is registered under CIN U24100HR2009PTC039273.

Sois Formulations has 3 current directors:

The latest financial statements of Sois Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Sois Formulations is 06AAOCS0304E1ZR, registered in Haryana.

The CIN (Corporate Identification Number) of Sois Formulations is U24100HR2009PTC039273. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sois Formulations was incorporated on 07 July 2009, making it 17+ years old. It is registered with the Registrar of Companies, Haryana.

The peers of Sois Formulations by revenue are Medicure Formulations Private Limited, Zaria Pharmaceuticals Private Limited, Med-Esales Life Sciences Private Limited, Cnscure India Private Limited, Regbex Life Sciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Aditya Gupta was appointed as Director on 01 Mar 2010. Kapil Gupta was appointed as Director on 07 Jul 2009. Sudhir Gupta was appointed as Director on 07 Jul 2009.

The registered office of Sois Formulations is at 626828 Nicholson Road, Ambala Cantt, Haryana, India – 133001.

Sois Formulations operates in the trading industry, in the other wholesale segment.

The compliance status of Sois Formulations is compliant as of 19 September 2026. The company is actively filing with the Registrar of Companies.